SPY305.55+1.23 0.40%
DIA255.27+0.98 0.39%
IXIC9,552.05+62.18 0.66%

Citigroup Maintains Buy on Guardant Health, Raises Price Target to $110

Citigroup maintains Guardant Health (NASDAQ:GH) with a Buy and raises the price target from $100 to $110.

Benzinga · 05/08/2020 11:22

Citigroup maintains Guardant Health (NASDAQ:GH) with a Buy and raises the price target from $100 to $110.